(Q33276646)

25 July 2017

1 reference

title

Photodynamic therapy and cancer: a brief sightseeing tour (English)

1 reference

25 July 2017

Giuseppe Palumbo

1

0 references

language of work or name

English

0 references

publication date

1 March 2007

1 reference

Expert Opinion on Drug Delivery

25 July 2017

published in

1 reference

25 July 2017

volume

4

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

131-148

1 reference

The photodynamic properties of a particular hematoporphyrin derivative

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Photofrin accumulation in malignant and host cell populations of various tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Localization of potent photosensitizers in human tumor LOX by means of laser scanning microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Role of cytokines in photodynamic therapy-induced local and systemic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Laser and non-laser light sources for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Measurement of the emission profiles of cylindrical light diffusers using a video technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Improvements in the design of linear diffusers for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Optical properties of human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

A review of progress in clinical photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

The present and future role of photodynamic therapy in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Photodynamic therapy: a clinical reality in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Pilot Study of Topical Delivery of Mono-L-aspartyl Chlorin e6 (NPe6): Implication of Topical NPe6-Photodynamic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Phase II clinical study of photodynamic therapy using mono-l-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Photodynamic therapy with 5,10,15,20-tetrakis(m-hydroxyphenyl) bacteriochlorin for colorectal liver metastases is safe and feasible: results from a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Interstitial photodynamic laser therapy for liver metastases: first results of a clinical phase I-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Hypericin--the facts about a controversial agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

A compilation of singlet oxygen yields from biologically relevant molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

New aspect of photodynamic diagnosis of bladder tumors: fluorescence cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Fluorescence detection of bladder cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor-alpha with dermatitis herpetiformis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Topical application of a first porphycene dye for photodynamic therapy--penetration studies in human perilesional skin and basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

In vivo and post mortem measurements of the attenuation spectra of light in mammalian tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Infrared laser activation of indocyanine green inhibits growth in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Indocyanine green nanoparticles useful for photomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Differential cell death response to photodynamic therapy is dependent on dose and cell type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Primary photodamage sites and mitochondrial events after Foscan photosensitization of MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Photodynamic effects induced by aminolevulinic acid esters on human cervical carcinoma cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Photodynamic therapy and anti-tumour immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Activation of the stress-activated JNK and p38 MAP kinases in human cells by Photofrin-mediated photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Distinct transduction mechanisms of cyclooxygenase 2 gene activation in tumour cells after photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy: Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

p53 Status does not affect photodynamic cell killing induced by hypericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Stress protein expression in murine tumor cells following photodynamic therapy with benzoporphyrin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Encapsulation of p-THPP into nanoparticles: cellular uptake, subcellular localization and effect of serum on photodynamic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Photobiological and ultrastructural studies of nanoparticles of poly(lactic-co-glycolic acid)-containing bacteriochlorophyll-a as a photosensitizer useful for PDT treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

The embedding of meta-tetra(hydroxyphenyl)-chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Diacyllipid micelle-based nanocarrier for magnetically guided delivery of drugs in photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Antibody-directed effector cell therapy of tumors: analysis and optimization using a physiologically based pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Enhanced delivery of 5-aminolevulinic acid esters by iontophoresis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

The use of ultrasound for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Effect of combined photodynamic and chemotherapeutic treatment on lymphoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.131

21 January 2018

Identifiers

DOI

10.1517/17425247.4.2.131

1 reference

release_jb5rgov6rnhidmfts2yoqd3jty

25 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jb5rgov6rnhidmfts2yoqd3jty

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference